|
HRP20180268T4
(hr)
*
|
2012-10-23 |
2026-03-27 |
Synaffix B.V. |
Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
|
|
EP3964237B1
(en)
|
2013-03-15 |
2026-02-18 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
DK2991683T3
(da)
*
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
AU2014311361B2
(en)
|
2013-08-26 |
2018-11-29 |
Regeneron Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
|
|
WO2015057066A1
(en)
*
|
2013-10-14 |
2015-04-23 |
Synaffix B.V. |
Glycoengineered antibody, antibody-conjugate and methods for their preparation
|
|
WO2015057064A1
(en)
*
|
2013-10-14 |
2015-04-23 |
Synaffix B.V. |
Modified glycoprotein, protein-conjugate and process for the preparation thereof
|
|
JP2016538877A
(ja)
*
|
2013-10-14 |
2016-12-15 |
シンアフィックス ビー.ブイ. |
修飾糖タンパク質、タンパク質コンジュゲート及びそれらの調製方法
|
|
WO2015088990A1
(en)
|
2013-12-09 |
2015-06-18 |
Durect Corporation |
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
|
|
CN106660967A
(zh)
|
2014-01-24 |
2017-05-10 |
西纳福克斯股份有限公司 |
(杂)芳基1,3‑偶极化合物与(杂)环炔的环加成方法
|
|
EP3097080A1
(en)
|
2014-01-24 |
2016-11-30 |
SynAffix B.V. |
Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
|
|
ES3060461T3
(en)
|
2014-04-08 |
2026-03-26 |
Univ Georgia |
Site-specific antibody-drug glycoconjugates and methods
|
|
US10973920B2
(en)
|
2014-06-30 |
2021-04-13 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
EP2974744A1
(en)
|
2014-07-16 |
2016-01-20 |
Stichting Katholieke Universiteit |
Strain-promoted oxidation controlled cycloaddition with high reaction rate
|
|
EP3177633B1
(en)
*
|
2014-08-04 |
2022-07-20 |
SynAffix B.V. |
Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
|
|
EP3733209A1
(en)
*
|
2014-10-03 |
2020-11-04 |
Synaffix B.V. |
Sulfamide linker, conjugates thereof, and methods of preparation
|
|
EP3903826B1
(en)
*
|
2014-12-04 |
2024-05-08 |
Celgene Corporation |
Biomolecule conjugates
|
|
EP3240797A4
(en)
*
|
2014-12-31 |
2018-08-01 |
Development Center for Biotechnology |
Site-specific conjugation through glycoproteins linkage and method thereof
|
|
US11559581B2
(en)
*
|
2015-01-09 |
2023-01-24 |
Oxford University Innovation Limited |
Antibody conjugates and methods of making the antibody conjugates
|
|
CA2978340C
(en)
|
2015-03-27 |
2024-05-28 |
Regeneron Pharmaceuticals, Inc. |
Maytansinoid derivatives, conjugates thereof, and methods of use
|
|
CN107810273B
(zh)
|
2015-04-23 |
2022-09-27 |
西纳福克斯股份有限公司 |
用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法
|
|
WO2016172615A1
(en)
*
|
2015-04-24 |
2016-10-27 |
University Of Delaware |
Synthetic n-acetyl-muramic acid derivatives and uses thereof
|
|
JP6993958B2
(ja)
|
2015-07-06 |
2022-02-04 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
多重特異性抗原結合分子およびその使用
|
|
CA2995145C
(en)
*
|
2015-08-26 |
2023-08-01 |
Vib Vzw |
Means and methods for monitoring inflammation
|
|
CN108699095B
(zh)
*
|
2015-10-07 |
2022-05-13 |
伊利诺伊大学评议会 |
用于癌症选择性标记和靶向的触发子可活化代谢糖前体
|
|
TWI660741B
(zh)
|
2015-11-03 |
2019-06-01 |
財團法人工業技術研究院 |
抗體藥物複合物及其製造方法
|
|
MA43416A
(fr)
|
2015-12-11 |
2018-10-17 |
Regeneron Pharma |
Méthodes pour ralentir ou empêcher la croissance de tumeurs résistantes au blocage de l'egfr et/ou d'erbb3
|
|
MX390630B
(es)
|
2016-01-25 |
2025-03-21 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos y metodos de uso.
|
|
RU2018128784A
(ru)
|
2016-01-27 |
2020-02-27 |
МЕДИММЬЮН, ЭлЭлСи |
Способы получения антител с заданным профилем гликозилирования
|
|
US10874746B2
(en)
|
2016-02-08 |
2020-12-29 |
Synaffix B.V. |
Sulfamide linkers for use in bioconjugates
|
|
EP3414328B1
(en)
|
2016-02-08 |
2024-01-10 |
Synaffix B.V. |
Enzymes for trimming of glycoproteins
|
|
WO2017137458A1
(en)
|
2016-02-08 |
2017-08-17 |
Synaffix B.V. |
Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates
|
|
JP2017197512A
(ja)
*
|
2016-02-08 |
2017-11-02 |
シンアフィックス ビー.ブイ. |
Cd30腫瘍を標的化するための改善された治療指数を有する新規な抗体−コンジュゲート及び抗体−コンジュゲートの治療指数を改善するための方法
|
|
US11590239B2
(en)
*
|
2016-02-08 |
2023-02-28 |
Synaffix B.V. |
Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugates
|
|
WO2017137456A1
(en)
|
2016-02-08 |
2017-08-17 |
Synaffix B.V. |
Bioconjugates containing sulfamide linkers for use in treatment
|
|
WO2017137457A1
(en)
|
2016-02-08 |
2017-08-17 |
Synaffix B.V. |
Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates
|
|
JP2017200902A
(ja)
*
|
2016-02-08 |
2017-11-09 |
シンアフィックス ビー.ブイ. |
Her2腫瘍を標的化するための改善された治療指数を有する新規な抗体−コンジュゲート及び抗体−コンジュゲートの治療指数を改善するための方法
|
|
MY199595A
(en)
|
2016-03-02 |
2023-11-08 |
Eisai R&D Man Co Ltd |
Eribulin-based antibody-drug conjugates and methods of use
|
|
WO2017190079A1
(en)
|
2016-04-28 |
2017-11-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
|
JP7020403B2
(ja)
*
|
2016-05-02 |
2022-02-16 |
味の素株式会社 |
アジド基含有Fcタンパク質
|
|
WO2017218891A1
(en)
*
|
2016-06-17 |
2017-12-21 |
Life Technologies Corporation |
Site-specific crosslinking of antibodies
|
|
EP4631529A3
(en)
|
2016-06-28 |
2026-03-11 |
Ventana Medical Systems, Inc. |
Application of click chemistry for signal amplification in ihc and ish assays
|
|
CN109462989A
(zh)
*
|
2016-07-01 |
2019-03-12 |
第三共株式会社 |
Hanp-含fc分子缀合物
|
|
WO2018002902A1
(en)
|
2016-07-01 |
2018-01-04 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Antibody-drug conjugates and therapeutic methods using the same
|
|
KR102520731B1
(ko)
*
|
2016-09-23 |
2023-04-14 |
리제너론 파아마슈티컬스, 인크. |
항-steap2 항체, 항체-약물 컨쥬게이트, 및 steap2 및 cd3에 결합하는 이중특이적 항원-결합 분자, 및 이의 용도
|
|
US10738338B2
(en)
|
2016-10-18 |
2020-08-11 |
The Research Foundation for the State University |
Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
|
|
CA3042428A1
(en)
|
2016-11-08 |
2018-05-17 |
Regeneron Pharmaceuticals, Inc. |
Steroids and protein-conjugates thereof
|
|
CN109996543A
(zh)
*
|
2016-11-14 |
2019-07-09 |
醣基生医股份有限公司 |
抗体药物复合体
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗met抗體,結合met之雙特異性抗原結合分子及其使用方法
|
|
JP6888764B2
(ja)
*
|
2016-12-29 |
2021-06-16 |
ディヴェロップメント センター フォー バイオテクノロジー |
糖タンパク質−薬物コンジュゲートを調製する方法
|
|
WO2018141959A1
(en)
|
2017-02-06 |
2018-08-09 |
Innate Pharma |
Immunomodulatory antibody drug conjugates binding to a human mica polypeptide
|
|
US11299509B2
(en)
|
2017-02-10 |
2022-04-12 |
The Board Of Trustees Of The University Of Illinois |
Trigger-activatable sugar conjugates for cancer-selective labeling and targeting
|
|
KR20200005635A
(ko)
|
2017-05-11 |
2020-01-15 |
브이아이비 브이지더블유 |
가변 면역글로불린 도메인의 글리코실화
|
|
KR20250008984A
(ko)
|
2017-05-18 |
2025-01-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
EP3625209A1
(en)
|
2017-05-18 |
2020-03-25 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
AU2018281280B2
(en)
|
2017-06-07 |
2024-12-19 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for internalizing enzymes
|
|
US11236059B2
(en)
|
2017-08-09 |
2022-02-01 |
Helmholtz-Zentrum Fuer Infektionsforschung Gmbh |
Targeted cytotoxic ratjadone derivatives and conjugates thereof
|
|
EP3441766B1
(en)
*
|
2017-08-11 |
2020-03-11 |
Life Science Inkubator Sachsen GmbH & Co. KG |
Novel antibody conjugates suitable for use in discrete fluorescence quenching displacement immunoassays
|
|
CA3177215C
(en)
*
|
2017-09-29 |
2026-06-09 |
Daiichi Sankyo Company, Limited |
Antibody-pyrrolobenzodiazepine derivative conjugate
|
|
CA3247730A1
(en)
|
2017-11-07 |
2025-10-30 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
CN111727075B
(zh)
|
2017-11-27 |
2024-04-05 |
普渡制药公司 |
靶向人组织因子的人源化抗体
|
|
EP3720504A1
(en)
|
2017-12-06 |
2020-10-14 |
Synaffix B.V. |
Enediyne conjugates
|
|
US11548908B2
(en)
|
2017-12-29 |
2023-01-10 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
MA50259A1
(fr)
|
2018-01-08 |
2021-07-29 |
Regeneron Pharma |
Stéroïdes et leurs conjugués-anticorps
|
|
JP7328990B2
(ja)
|
2018-04-30 |
2023-08-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Her2及び/またはaplp2に結合する抗体及び二重特異性抗原結合分子、ならびにそれらのコンジュゲート及び使用
|
|
WO2019217591A1
(en)
|
2018-05-09 |
2019-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-msr1 antibodies and methods of use thereof
|
|
EP3793591A1
(en)
|
2018-05-17 |
2021-03-24 |
Regeneron Pharmaceuticals, Inc. |
Anti-cd63 antibodies, conjugates, and uses thereof
|
|
JP2019206491A
(ja)
*
|
2018-05-29 |
2019-12-05 |
国立研究開発法人理化学研究所 |
乳がんまたは胃がんの治療のための抗体−薬物複合体
|
|
JP7273858B2
(ja)
*
|
2018-06-15 |
2023-05-15 |
シャンハイ ミラコーケン インコーポレイティド |
癌を治療するための方法と材料
|
|
CN112955154A
(zh)
*
|
2018-08-02 |
2021-06-11 |
达因疗法公司 |
肌肉靶向复合物及其用于治疗强直性肌营养不良的用途
|
|
WO2020028832A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
US12370264B1
(en)
|
2018-08-02 |
2025-07-29 |
Dyne Therapeutics, Inc. |
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
|
|
AU2019315593B2
(en)
*
|
2018-08-02 |
2026-05-21 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes and uses thereof
|
|
US11168141B2
(en)
|
2018-08-02 |
2021-11-09 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
EP3830259A4
(en)
|
2018-08-02 |
2022-05-04 |
Dyne Therapeutics, Inc. |
MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
|
|
US12097263B2
(en)
|
2018-08-02 |
2024-09-24 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
US12018087B2
(en)
|
2018-08-02 |
2024-06-25 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
|
|
US11911484B2
(en)
*
|
2018-08-02 |
2024-02-27 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
EP3876998A1
(en)
*
|
2018-11-05 |
2021-09-15 |
Synaffix B.V. |
Antibody-conjugates for targeting of tumours expressing trop-2
|
|
CA3120528A1
(en)
|
2018-11-20 |
2020-05-28 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
WO2020132483A1
(en)
|
2018-12-21 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
WO2020132658A2
(en)
|
2018-12-21 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
JP7547345B2
(ja)
|
2018-12-27 |
2024-09-09 |
グリコミメティクス, インコーポレイテッド |
ガレクチン-3阻害性c-グリコシド
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
JP2022517767A
(ja)
|
2019-01-08 |
2022-03-10 |
レゲネロン ファーマシューティカルス,インコーポレーテッド |
無痕跡型リンカー及びそのタンパク質-コンジュゲート
|
|
GB201901608D0
(en)
|
2019-02-06 |
2019-03-27 |
Vib Vzw |
Vaccine adjuvant conjugates
|
|
KR20210130755A
(ko)
|
2019-02-21 |
2021-11-01 |
리제너론 파마슈티칼스 인코포레이티드 |
항-met 항체 및 met에 결합하는 이중특이적 항원 결합 분자를 사용하여 안구암을 치료하는 방법
|
|
EP3950061A4
(en)
*
|
2019-03-25 |
2022-11-16 |
Daiichi Sankyo Company, Limited |
ANTIBODY PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE
|
|
BR112021017616A2
(pt)
*
|
2019-03-25 |
2021-11-09 |
Daiichi Sankyo Co Ltd |
Conjugado de derivado de anticorpo anti-her2-pirrolobenzodiazepina
|
|
EP3949988A4
(en)
*
|
2019-03-27 |
2022-11-16 |
Daiichi Sankyo Company, Limited |
COMBINATION OF AN ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE AND A PARP INHIBITOR
|
|
EP3976112A1
(en)
|
2019-06-03 |
2022-04-06 |
Synaffix B.V. |
Acetal-based cleavable linkers
|
|
CN114340684B
(zh)
|
2019-09-16 |
2025-09-12 |
瑞泽恩制药公司 |
用于免疫pet成像的放射性标记的met结合蛋白
|
|
US11814428B2
(en)
|
2019-09-19 |
2023-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-PTCRA antibody-drug conjugates and uses thereof
|
|
EP3828196A4
(en)
*
|
2019-09-29 |
2022-04-27 |
MabPlex International Co., Ltd. |
METHOD FOR PREPARING AN INTERMEDIATE ANTIBODY-DRUG CONJUGATE BY ACID METHOD AND APPLICATION THEREOF
|
|
US20240148891A1
(en)
|
2019-10-18 |
2024-05-09 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
GB201917388D0
(en)
*
|
2019-11-28 |
2020-01-15 |
Cambridge Entpr Ltd |
Novel linker compounds
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
BR112022013255A2
(pt)
|
2020-01-09 |
2022-09-06 |
Mersana Therapeutics Inc |
Conjugados anticorpo-fármaco específicos de sítio com ligantes contendo peptídeo
|
|
JP7858532B2
(ja)
|
2020-01-10 |
2026-05-14 |
ダイン セラピューティクス,インコーポレーテッド |
筋肉標的複合体および筋肉の健康に関連する遺伝子のモジュレーションのためのその使用
|
|
JP7807376B2
(ja)
|
2020-01-13 |
2026-01-27 |
シンアフィックス ビー.ブイ. |
付加環化を介して両側官能化された抗体
|
|
WO2021144314A1
(en)
|
2020-01-13 |
2021-07-22 |
Synaffix B.V. |
Via cycloaddition bilaterally functionalized antibodies
|
|
CN115768483A
(zh)
|
2020-01-13 |
2023-03-07 |
西纳福克斯股份有限公司 |
抗体与免疫细胞衔接器的缀合物
|
|
MX2022008901A
(es)
|
2020-01-24 |
2022-08-16 |
Regeneron Pharma |
Conjugados de proteinas-compuestos antivirales.
|
|
WO2021154477A1
(en)
|
2020-01-31 |
2021-08-05 |
Dyne Therapeutics, Inc. |
Anti-transferrin receptor (tfr) antibody and uses thereof
|
|
CA3166619A1
(en)
|
2020-02-28 |
2021-09-02 |
Julian Andreev |
Bispecific antigen binding molecules that bind her2, and methods of use thereof
|
|
MX2022012821A
(es)
|
2020-04-16 |
2022-11-07 |
Regeneron Pharma |
Metodos de conjugacion de diels-alder.
|
|
AU2021273014A1
(en)
|
2020-05-13 |
2022-11-17 |
AbbVie Deutschland GmbH & Co. KG |
Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease
|
|
ES3075793T3
(en)
|
2020-05-13 |
2026-08-07 |
Disc Medicine Inc |
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
|
|
US20230183347A1
(en)
|
2020-05-25 |
2023-06-15 |
Foundation For Biomedical Research And Innovation At Kobe |
PD-1 Agonist-Containing Pharmaceutical Composition for Treating or PReventing TH2-Mediated Disease
|
|
CN111560078A
(zh)
*
|
2020-06-19 |
2020-08-21 |
联宁(苏州)生物制药有限公司 |
具有马来酰亚胺接头的双臂中间体及其合成方法
|
|
MX2022015769A
(es)
|
2020-06-24 |
2023-01-19 |
Regeneron Pharma |
Tubulisinas y conjugados de proteina-tubulisina.
|
|
WO2021260232A1
(en)
|
2020-06-26 |
2021-12-30 |
Synaffix B.V. |
Methods for the preparation of linker payload constructs
|
|
US12605459B2
(en)
|
2020-07-13 |
2026-04-21 |
Regeneron Pharmaceuticals, Inc. |
Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
|
|
US11771776B2
(en)
|
2021-07-09 |
2023-10-03 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
US11638761B2
(en)
|
2021-07-09 |
2023-05-02 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
|
|
US11969475B2
(en)
|
2021-07-09 |
2024-04-30 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
|
|
US11672872B2
(en)
|
2021-07-09 |
2023-06-13 |
Dyne Therapeutics, Inc. |
Anti-transferrin receptor antibody and uses thereof
|
|
US11633498B2
(en)
|
2021-07-09 |
2023-04-25 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
NL2026400B1
(en)
*
|
2020-09-02 |
2022-05-04 |
Synaffix Bv |
Methods for the preparation of bioconjugates
|
|
JP2023542295A
(ja)
|
2020-09-14 |
2023-10-06 |
リジェネロン ファーマシューティカルズ,インク. |
Glp1ペプチド模倣薬を含む抗体薬物複合体及びその使用
|
|
JP7904824B2
(ja)
|
2020-09-15 |
2026-08-13 |
シンアフィックス ビー.ブイ. |
抗体-エクサテカンコンジュゲート
|
|
US20230372528A1
(en)
|
2020-10-16 |
2023-11-23 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
MX2023004395A
(es)
*
|
2020-10-16 |
2023-05-22 |
Univ Georgia |
Glicoconjugados.
|
|
US11866502B2
(en)
|
2020-10-22 |
2024-01-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-FGFR2 antibodies and methods of use thereof
|
|
NL2026947B1
(en)
|
2020-11-20 |
2022-07-01 |
Synaffix Bv |
Tyrosine-based antibody conjugates
|
|
WO2022136705A1
(en)
|
2020-12-24 |
2022-06-30 |
Synaffix B.V. |
Glycan-conjugated antibodies binding to fc-gamma receptor
|
|
AU2021414227A1
(en)
|
2020-12-31 |
2023-07-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
JP2024506022A
(ja)
|
2021-02-08 |
2024-02-08 |
シンアフィックス ビー.ブイ. |
多機能性抗体
|
|
WO2022217022A1
(en)
|
2021-04-10 |
2022-10-13 |
Profoundbio Us Co. |
Folr1 binding agents, conjugates thereof and methods of using the same
|
|
CA3216459A1
(en)
|
2021-04-23 |
2022-10-27 |
Profoundbio Us Co. |
Anti-cd70 antibodies, conjugates thereof and methods of using the same
|
|
WO2023283623A1
(en)
|
2021-07-09 |
2023-01-12 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and formulations for treating dystrophinopathies
|
|
KR20240038928A
(ko)
|
2021-07-28 |
2024-03-26 |
리제너론 파마슈티칼스 인코포레이티드 |
단백질-항바이러스 화합물 접합체
|
|
US20240350658A1
(en)
*
|
2021-10-20 |
2024-10-24 |
Glyco-Therapy Biotechnology Co., Ltd. |
Site-specific glycoprotein conjugates and methods for making the same
|
|
KR102782629B1
(ko)
*
|
2021-11-12 |
2025-03-19 |
닥터아이앤비(주) |
생산 시간을 단축하고 안정성이 개선된 의약품 제조방법
|
|
EP4433160A1
(en)
|
2021-11-17 |
2024-09-25 |
Disc Medicine, Inc. |
Methods for treating anemia of kidney disease
|
|
WO2023129518A1
(en)
|
2021-12-29 |
2023-07-06 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
MX2024008640A
(es)
|
2022-01-12 |
2024-07-24 |
Regeneron Pharma |
Analogos de camptotecina conjugados a un residuo de glutamina en una proteina y su uso.
|
|
MX2024008361A
(es)
|
2022-01-14 |
2024-09-10 |
Regeneron Pharma |
Derivados de verrucarina a y conjugados anticuerpo-fármaco de los mismos.
|
|
WO2023141855A1
(en)
*
|
2022-01-27 |
2023-08-03 |
Glyco-Therapy Biotechnology Co., Ltd. |
Protein conjugates with multiple payloads and methods for making the same
|
|
JP2025505835A
(ja)
|
2022-02-22 |
2025-02-28 |
アーデーセー セラピューティクス ソシエテ アノニム |
トリミングされたn-グリカンを含むfc領域でのトランスグルタミナーゼを伴うコンジュゲーション方法
|
|
CA3243669A1
(en)
|
2022-03-11 |
2023-09-14 |
Regeneron Pharmaceuticals, Inc. |
ANTI-GLP1R ANTIBODY-DRUG CONJUGATES INCLUDING GLP1 PEPTIDOMIMETS AND THEIR USES
|
|
MX2024011519A
(es)
|
2022-03-23 |
2024-09-24 |
Synaffix Bv |
Conjugados de anticuerpos para el direccionamiento contra tumores que expresan el antigeno carcinoembrionario.
|
|
US20250205353A1
(en)
|
2022-03-23 |
2025-06-26 |
Synaffix B.V. |
Antibody-conjugates for targeting of tumours expressing nectin-4
|
|
IL315366A
(en)
|
2022-03-23 |
2024-11-01 |
Synaffix Bv |
Antibody pairs for targeting PTK7-expressing tumors
|
|
CA3253220A1
(en)
|
2022-03-23 |
2023-09-28 |
Synaffix B.V. |
ANTIBODIES CONJUGATED FOR TARGETING TUMORS EXPRESSING TROP-2
|
|
IL316143A
(en)
|
2022-04-15 |
2024-12-01 |
Dyne Therapeutics Inc |
Muscle targeting complexes and formulations for the treatment of myotonic dystrophy
|
|
EP4285934A1
(en)
|
2022-05-30 |
2023-12-06 |
CER Groupe |
Modified trimannose-oligosacharides, bisected n-glycans comprising said trimannose core and method for obtaining them
|
|
WO2024020164A2
(en)
|
2022-07-21 |
2024-01-25 |
Firefly Bio, Inc. |
Glucocorticoid receptor agonists and conjugates thereof
|
|
EP4572798A1
(en)
|
2022-08-15 |
2025-06-25 |
Synaffix B.V. |
Anthracyclins and conjugates thereof
|
|
EP4344707A1
(en)
|
2022-09-29 |
2024-04-03 |
Emergence Therapeutics AG |
New anti-nectin-4 antibody drug conjugates
|
|
EP4626553A2
(en)
|
2022-11-30 |
2025-10-08 |
Regeneron Pharmaceuticals, Inc. |
Tlr7 agonists and antibody-drug-conjugates thereof
|
|
WO2024121123A1
(en)
|
2022-12-06 |
2024-06-13 |
Synaffix B.V. |
Synthesis of endo-bicyclononene
|
|
WO2024138000A1
(en)
|
2022-12-21 |
2024-06-27 |
Regeneron Pharmaceuticals, Inc. |
Prodrugs of topoisomerase i inhibitor for adc conjugations and methods of use thereof
|
|
JP2026504737A
(ja)
*
|
2022-12-22 |
2026-02-09 |
ヤンセン ファーマシューティカ エヌ.ベー. |
抗体-ポリヌクレオチドコンジュゲートを調製する方法
|
|
EP4389152A1
(en)
|
2022-12-23 |
2024-06-26 |
Synaffix B.V. |
Conjugates of pbd prodrugs
|
|
WO2024150074A2
(en)
|
2023-01-13 |
2024-07-18 |
Takeda Pharmaceutical Company Limited |
Coronavirus antibodies and therapeutic uses thereof
|
|
EP4653020A1
(en)
|
2023-01-19 |
2025-11-26 |
Shanghai Shengdi Pharmaceutical Co., Ltd |
Tyrosinase-mediated protein site-specific conjugation and use thereof
|
|
EP4410313A1
(en)
|
2023-01-31 |
2024-08-07 |
Synaffix B.V. |
Homogeneous antibody-conjugates with high payload loading
|
|
WO2024168199A1
(en)
|
2023-02-09 |
2024-08-15 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates via inverse electron demand diels-alder reactions
|
|
AU2024229544A1
(en)
|
2023-03-02 |
2025-10-16 |
Alloy Therapeutics, Inc. |
Anti-cd22 antibodies and uses thereof
|
|
WO2024199442A1
(en)
*
|
2023-03-30 |
2024-10-03 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Disaccharide linker, linker-payload containing the same and glycan chain-remodeled antibody-drug conjugate, preparation method and uses thereof
|
|
CN120981487A
(zh)
*
|
2023-03-30 |
2025-11-18 |
启德医药科技(苏州)有限公司 |
位点特异性正交生物偶联模式及其应用
|
|
EP4450093A1
(en)
|
2023-04-17 |
2024-10-23 |
Synaffix B.V. |
Cleavable immune cell engagers
|
|
WO2024218162A1
(en)
|
2023-04-17 |
2024-10-24 |
Synaffix B.V. |
Cleavable immune cell engagers
|
|
EP4450489A1
(en)
|
2023-04-18 |
2024-10-23 |
Synaffix B.V. |
Stable 4-isoxazoline conjugates
|
|
CN121039163A
(zh)
|
2023-05-02 |
2025-11-28 |
瑞泽恩制药公司 |
抗人m-钙粘蛋白(cdh15)抗体、缀合物及其用于将遗传有效负载递送至肌肉细胞的用途
|
|
TW202509060A
(zh)
|
2023-05-08 |
2025-03-01 |
法商賽諾菲公司 |
免疫球蛋白單可變結構域的醣基化
|
|
EP4719482A1
(en)
|
2023-06-05 |
2026-04-08 |
Vib Vzw |
Glyco-engineered antibody-drug-conjugates comprising an oxime linker
|
|
IL325400A
(en)
|
2023-07-10 |
2026-02-01 |
Regeneron Pharma |
Anti-human CACNG1 antibody-drug conjugates and their uses
|
|
JP2026523745A
(ja)
*
|
2023-07-10 |
2026-07-14 |
スリオ セラピューティクス シーオー., エルティーディー. |
官能基化アウリスタチン、医薬組成物、及び治療的応用
|
|
KR20260044219A
(ko)
|
2023-07-21 |
2026-04-01 |
매로우 테라퓨틱스, 인크. |
조혈 세포 표적화 접합체 및 관련 방법
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
AR133955A1
(es)
|
2023-09-26 |
2025-11-19 |
Profoundbio Us Co |
Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
|
|
EP4541376A1
(en)
|
2023-10-17 |
2025-04-23 |
ADC Therapeutics SA |
Antibody-drug conjugates
|
|
CN122295135A
(zh)
|
2023-11-03 |
2026-06-26 |
瑞泽恩制药公司 |
作为glp1r激动剂的肽酸及其抗体-药物缀合物
|
|
WO2025117727A1
(en)
|
2023-11-29 |
2025-06-05 |
Regeneron Pharmaceuticals, Inc. |
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof
|
|
TW202530255A
(zh)
|
2023-12-15 |
2025-08-01 |
法商亞維西亞有限公司 |
抗il-1rap結合結構域及其抗體-藥物偶聯物
|
|
EP4574174A1
(en)
|
2023-12-19 |
2025-06-25 |
Jack Elands |
Novel antibody-drug conjugates comprising an anti-(tcr)-cd3-complex binding antibody
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
WO2025163120A1
(en)
|
2024-02-01 |
2025-08-07 |
Adcytherix Sas |
ANTIBODY-DRUG CONJUGATES COMPRISING AN ANTI-INTEGRIN ΑVβ6 BINDING ANTIBODY
|
|
WO2025172468A1
(en)
|
2024-02-13 |
2025-08-21 |
Synaffix B.V. |
Method for producing azido-sugars and compounds obtained thereby
|
|
WO2025181219A1
(en)
|
2024-02-29 |
2025-09-04 |
Genmab A/S |
Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same
|
|
WO2025238253A1
(en)
|
2024-05-16 |
2025-11-20 |
Synaffix B.V. |
Antibody-oligonucleotide conjugates
|
|
WO2025262641A1
(en)
|
2024-06-19 |
2025-12-26 |
Pheon Therapeutics Ltd |
Antibody drug conjugates that bind cdcp1 and uses thereof
|
|
WO2026006494A1
(en)
|
2024-06-25 |
2026-01-02 |
Alloy Therapeutics, Inc. |
Anti-cd3 antibodies and uses thereof
|
|
WO2026006495A1
(en)
|
2024-06-25 |
2026-01-02 |
Alloy Therapeutics, Inc. |
Anti-wt1/hla-a2 antibody and uses thereof
|
|
WO2026006492A2
(en)
|
2024-06-25 |
2026-01-02 |
Ypsilon Therapeutics, Inc. |
Anti-prame/hla-a2 antibodies and uses thereof
|
|
WO2026008881A1
(en)
|
2024-07-05 |
2026-01-08 |
Synaffix B.V. |
Extracellular vesicles comprising biomolecule-conjugates
|
|
US20260078179A1
(en)
|
2024-07-18 |
2026-03-19 |
Novarock Biotherapeutics, Ltd. |
Cdh17 antibodies and uses thereof
|
|
WO2026035986A1
(en)
|
2024-08-07 |
2026-02-12 |
Bighat Biosciences, Inc. |
Humanized anti-cdh17 antibodies and use of the same
|
|
WO2026039642A1
(en)
|
2024-08-16 |
2026-02-19 |
Ardeagen Corporation |
Anti-mesothelin antibody conjugates and methods of use thereof
|
|
WO2026052513A1
(en)
|
2024-09-09 |
2026-03-12 |
Adcytherix Sas |
Antibody-drug conjugates comprising an flt3 binding antibody
|
|
WO2026105061A1
(en)
|
2024-11-15 |
2026-05-21 |
Pheon Therapeutics Ltd |
Antibody-drug conjugates that bind cdcp1 and uses thereof
|
|
US12673112B2
(en)
|
2024-12-09 |
2026-07-07 |
Takeda Pharmaceutical Company Limited |
CCR8 antibodies, antibody conjugates, and uses thereof
|
|
WO2026124448A1
(zh)
*
|
2024-12-10 |
2026-06-18 |
东曜药业有限公司 |
蛋白药物偶联物的制备方法
|